16-2300067-C-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_001089.3(ABCA3):​c.1549G>A​(p.Glu517Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000201 in 1,613,684 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00038 ( 1 hom., cov: 30)
Exomes 𝑓: 0.00018 ( 0 hom. )

Consequence

ABCA3
NM_001089.3 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.42

Publications

3 publications found
Variant links:
Genes affected
ABCA3 (HGNC:33): (ATP binding cassette subfamily A member 3) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. The full transporter encoded by this gene may be involved in development of resistance to xenobiotics and engulfment during programmed cell death. [provided by RefSeq, Jul 2008]
ABCA3 Gene-Disease associations (from GenCC):
  • interstitial lung disease due to ABCA3 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.025774598).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000382 (58/151888) while in subpopulation AMR AF = 0.00243 (37/15224). AF 95% confidence interval is 0.00181. There are 1 homozygotes in GnomAd4. There are 33 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCA3NM_001089.3 linkc.1549G>A p.Glu517Lys missense_variant Exon 13 of 33 ENST00000301732.10 NP_001080.2 Q99758-1Q4LE27

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCA3ENST00000301732.10 linkc.1549G>A p.Glu517Lys missense_variant Exon 13 of 33 1 NM_001089.3 ENSP00000301732.5 Q99758-1
ABCA3ENST00000382381.7 linkc.1375G>A p.Glu459Lys missense_variant Exon 12 of 32 1 ENSP00000371818.3 H0Y3H2
ABCA3ENST00000563623.5 linkn.2112G>A non_coding_transcript_exon_variant Exon 13 of 20 1

Frequencies

GnomAD3 genomes
AF:
0.000382
AC:
58
AN:
151770
Hom.:
1
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00243
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000378
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000203
AC:
51
AN:
251444
AF XY:
0.000199
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000601
Gnomad NFE exome
AF:
0.000185
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000182
AC:
266
AN:
1461796
Hom.:
0
Cov.:
32
AF XY:
0.000166
AC XY:
121
AN XY:
727190
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.000492
AC:
22
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.000525
AC:
28
AN:
53326
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.000170
AC:
189
AN:
1112012
Other (OTH)
AF:
0.000397
AC:
24
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
18
36
54
72
90
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000382
AC:
58
AN:
151888
Hom.:
1
Cov.:
30
AF XY:
0.000445
AC XY:
33
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41436
American (AMR)
AF:
0.00243
AC:
37
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4762
European-Finnish (FIN)
AF:
0.000378
AC:
4
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
67926
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000189
Hom.:
0
Bravo
AF:
0.000416
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000165
AC:
20
EpiCase
AF:
0.000327
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Nov 08, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant classified as Uncertain Significance - Favor Benign. The Glu517Lys varia nt in ABCA3 has not been previously identified in individuals with pulmonary dis ease. This variant has been identified in 1/8600 European American chromosomes b y the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP r s201157181). Glutamic acid (Glu) at position 517 is poorly conserved in evolutio n and at least 2 mammals (tarsier and alpaca) carry the variant amino acid, rais ing the possibility that this change may be tolerated. Additional computational analyses (biochemical amino acid properties, AlignGVGD, PolyPhen2, and SIFT) sug gest that the Glu517Lys variant may not impact the protein, though this informat ion is not predictive enough to rule out pathogenicity. In summary, this variant is less likely disease causing but additional information is needed to fully as sess its clinical significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.12
CADD
Benign
22
DANN
Benign
0.79
DEOGEN2
Benign
0.13
T;.
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.55
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.75
T;T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.026
T;T
MetaSVM
Benign
-0.58
T
MutationAssessor
Benign
1.6
L;.
PhyloP100
4.4
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-0.48
N;N
REVEL
Uncertain
0.34
Sift
Benign
0.57
T;T
Sift4G
Benign
0.53
T;T
Polyphen
0.11
B;.
Vest4
0.47
MVP
0.73
MPC
0.26
ClinPred
0.054
T
GERP RS
2.8
Varity_R
0.053
gMVP
0.90
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201157181; hg19: chr16-2350068; COSMIC: COSV57057524; API